Speciality Medicines Limited (BOM:544738)

Speciality Medicines Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	245.46	8.46	2.49	2.62	0.77
Cash & Short-Term Investments	245.46	8.46	2.49	2.62	0.77
Cash Growth	2802.06%	239.81%	-4.83%	241.00%	-
Accounts Receivable	265.01	96.05	107.13	55.06	25.91
Other Receivables	-	7.57	7.35	7.45	1.64
Receivables	361.05	104.05	114.81	62.73	27.55
Inventory	283.17	173.76	80.31	45.95	4.83
Other Current Assets	-	77.94	11.88	2.11	2.35
Total Current Assets	889.67	364.21	209.49	113.4	35.5
Property, Plant & Equipment	17.13	18.67	14.71	16.93	19.08
Long-Term Investments	3.04	1.02	1	1	2.11
Other Intangible Assets	0.92	1.02	0.88	0.73	0.73
Long-Term Deferred Tax Assets	-	-	0.18	-	0.05
Other Long-Term Assets	41.48	15.24	7.02	0.3	0.3
Total Assets	952.23	400.15	233.27	132.35	57.76

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	119.16	9.71	24.15	18.02	11.83
Accrued Expenses	24.92	0.35	1.52	0.53	0.67
Short-Term Debt	-	11.95	17.25	16.91	11.78
Current Portion of Long-Term Debt	16.24	12.44	2.88	-	-
Current Income Taxes Payable	-	14.94	6.72	-	6.64
Other Current Liabilities	27.94	16.8	4.9	12.77	7.4
Total Current Liabilities	188.26	66.18	57.41	48.24	38.32
Long-Term Debt	50.18	26.08	8.45	19.49	-
Pension & Post-Retirement Benefits	1.57	1.24	0.6	-	0.12
Long-Term Deferred Tax Liabilities	0.29	0.43	-	-	-
Other Long-Term Liabilities	-	-	-	0.12	-
Total Liabilities	240.3	93.93	66.46	67.84	38.44

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	87.86	64.36	51.17	38.2	2.1
Additional Paid-In Capital	-	103.28	49.02	-	2.43
Retained Earnings	-	-	-	26.31	14.79
Comprehensive Income & Other	624.07	138.58	66.62	-	-
Shareholders' Equity	711.93	306.22	166.81	64.51	19.32
Total Liabilities & Equity	952.23	400.15	233.27	132.35	57.76

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	66.42	50.47	28.58	36.4	11.78
Net Cash (Debt)	179.03	-42.01	-26.09	-33.78	-11.01
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	27.63	-6.53	-5.10	-9.44	-3.62
Filing Date Shares Outstanding	6.48	6.44	6.44	3.82	3.04
Total Common Shares Outstanding	6.48	6.44	5.12	3.82	3.04
Working Capital	701.41	298.03	152.08	65.16	-2.82
Book Value Per Share	109.85	47.58	32.60	16.89	6.36
Tangible Book Value	711.01	305.2	165.93	63.78	18.6
Tangible Book Value Per Share	109.71	47.42	32.43	16.70	6.12
Land	-	5.58	-	-	-
Buildings	-	15.75	15.75	15.74	15.75
Machinery	-	5.62	5.35	5.25	4.45

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error